| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
ArriVent BioPharma, Inc.
13G/A
AVBP · 04272N102
|
9.9% |
2/17/2026
Event 12/31/2025
|
||||
| Infinitum Asset Management, LLC | 9.9% | |||||
| Infinitum Partners GP, LLC | 9.9% | |||||
| Infinitum Cayman Master, Ltd. | 9.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.